PRELUDE THERAPEUTICS INC shareholders Q3 2023

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 61 filers reported holding PRELUDE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 6.00 and the average weighting 0.0%.

PRELUDE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Citadel Advisors 300,101$927,3120.00%
TWO SIGMA ADVISERS, LP 31,100$96,0990.00%
Daiwa Securities Group Inc. 104$00.00%
SIMPLEX TRADING, LLC 31$00.00%
Nuveen Asset Management, LLC 13,804$42,6540.00%
HighMark Wealth Management LLC 50$1550.00%
Tower Research Capital LLC (TRC) 3,500$10,8150.00%
Cutler Group LLC / CA 130$00.00%
Allspring Global Investments Holdings, LLC 6,107$18,8700.00%
JPMORGAN CHASE & CO 17,353$53,6210.00%
BARCLAYS PLC 13,316$420.00%
ROYAL BANK OF CANADA 5,063$15,0000.00%
D. E. Shaw & Co., Inc. 49,184$151,9790.00%
VANGUARD GROUP INC 973,606$3,008,4420.00%
Ameritas Investment Partners, Inc. 819$2,5310.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 3,140$9,7030.00%
UBS Group AG 7,408$22,8910.00%
RHUMBLINE ADVISERS 33,815$104,4770.00%
TWO SIGMA INVESTMENTS, LP 12,813$39,5920.00%
DIMENSIONAL FUND ADVISORS LP 11,188$34,5020.00%
External links

This page lists PRELUDE THERAPEUTICS INC's shareholders in Q3 2023. To view PRELUDE THERAPEUTICS INC's shareholder history, click here.